Learning Objectives
- In-depth discussions on the most influential oncology trials presented in 2024 across various disease sites, highlighting key findings and their implications for clinical practice.
- Comprehensive reviews of up-to-date standard treatment protocols for major hematological malignancies, ensuring healthcare professionals are informed about best practices and therapeutic options available.
- Discussions on the current controversies in the management of specific hematological cancers.
Co-Chairs
Dr. Martina Trinkaus
Dr. Matthew Seftel
